The most commonly prescribed drug, methylphenidate, can cost private patients between £15 and £50 per month. Whilst ...

Adults with attention-deficit/hyperactivity disorder (ADHD) who use an extended-release medication are more likely to ...

Did you know the attention, memory, and motivation challenges associated with ADHD are rooted in biology? Learn how the brain ...

Both children and adults with ADHD may show inattentiveness, excessive movement, impulsivity and challenges in executive ...

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first ...

Because people with ADHD often find it hard to regulate their behaviors and emotions, psychotherapy is also commonly used as ...

With no current drug treatment to assist people in getting ... given to study participants was high. For adults and children with ADHD, the starting dose is 30 mg a day, which is slowly increased ...

Cingulate Inc. (NASDAQ:CING) announced the successful completion of its final FDA-required study for CTx-1301 (dexmethylphenidate) aimed at treating Attention Deficit Hyperactivity Disorder (ADHD).

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Cingulate Inc ...